CANF
Can-Fite BioPharma
CANF
CANF
7 hedge funds and large institutions have $1.61M invested in Can-Fite BioPharma in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$0 |
| 2 |
2
Simplex Trading
Chicago,
Illinois
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $1.43M | 796,500 | – | – |
|
|
PVH
2
Psagot Value Holdings
Tel Aviv,
Israel
| $61K | 34,126 | +30,917 | +963% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $39K | 21,565 | +21,565 | New |
|
4
Citadel Advisors
Miami,
Florida
| $30K | 16,738 | +16,738 | New |
|
5
Morgan Stanley
New York
| $22K | 12,300 | +11,800 | +2,360% |
|
|
RJA
6
Raymond James & Associates
St Petersburg,
Florida
| $22K | 12,200 | +12,200 | New |
|
|
PCM
7
Prelude Capital Management
New York
| $1K | 800 | +800 | New |
|
|
SM
8
Sabby Management
Miami Beach,
Florida
| – | – | -30,017 | Closed |
|
|
9
Simplex Trading
Chicago,
Illinois
| – | – | -1,000 | Closed |
|